Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register‐based drug utilization study | ||
| dc.conicet.organizacion | Technical University of Denmark | |
| dc.conicet.organizacion | Technical University of Denmark | |
| dc.conicet.organizacion | Norwegian Institute of Public Health | |
| dc.conicet.organizacion | Karolinska Huddinge Hospital. Karolinska Institutet | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Karolinska Huddinge Hospital. Karolinska Institutet | |
| dc.conicet.organizacion | Norwegian Institute Of Public Health | |
| dc.conicet.organizacion | Technical University of Denmark | |
| dc.contributor.author | Rasmussen, Lotte | |
| dc.contributor.author | Andersen, Jacob Harbo | |
| dc.contributor.author | Karlstad, Øystein | |
| dc.contributor.author | Giunta, Diego Hernan | |
| dc.contributor.author | Linder, Marie | |
| dc.contributor.author | Furu, Kari | |
| dc.contributor.author | Pottegård, Anton | |
| dc.date.issued | 2024-08 | |
| dc.description.abstract | The use of glucose-lowering drugs has changed considerably duringthe last decade.1,2 To understand the role of semaglutide in the treat-ment of type 2 diabetes, we aimed firstly to describe the uptake inadults in the early phases after launch in three Scandinavian countries,including the impact of semaglutide on the use of other glucagon-likepeptide-1 receptor agonists (GLP-1RAs) indicated for treatment oftype 2 diabetes. Secondly, we aimed to compare the characteristicsof semaglutide initiators with those of initiators of liraglutide andother glucose-lowering drugs and to compare early versus late initia-tors of subcutaneous semaglutide in Denmark. | es |
| dc.description.fil | Fil: Rasmussen, Lotte. Technical University of Denmark; Dinamarca | |
| dc.description.fil | Fil: Andersen, Jacob Harbo. Technical University of Denmark; Dinamarca | |
| dc.description.fil | Fil: Karlstad, Øystein. Norwegian Institute of Public Health; Noruega | |
| dc.description.fil | Fil: Giunta, Diego Hernan. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Linder, Marie. Karolinska Huddinge Hospital. Karolinska Institutet; Suecia | |
| dc.description.fil | Fil: Furu, Kari. Norwegian Institute Of Public Health; Noruega | |
| dc.description.fil | Fil: Pottegård, Anton. Technical University of Denmark; Dinamarca | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Rasmussen, Lotte; Andersen, Jacob Harbo; Karlstad, Øystein; Giunta, Diego Hernan; Linder, Marie; et al.; Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register‐based drug utilization study; Wiley Blackwell Publishing, Inc; Diabetes Obesity & Metabolism; 26; 11; 8-2024; 5479-5482 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1462-8902 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/297238 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 11 | es |
| dc.journal.pagination | 5479-5482 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Diabetes Obesity & Metabolism | es |
| dc.journal.volume | 26 | es |
| dc.language.iso | eng | es |
| dc.publisher | Wiley Blackwell Publishing, Inc | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15876 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1111/dom.15876 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc/2.5/ar/ | * |
| dc.subject | ANTIDIABETIC DRUG | es |
| dc.subject | DATABASE RESEARCH | es |
| dc.subject | LIRAGLUTIDE | es |
| dc.subject | PHARMACOEPIDEMIOLOGY | es |
| dc.subject | SEMAGLUTIDE | es |
| dc.subject.classification | Otras Medicina Clínica | es |
| dc.subject.classification | Medicina Clínica | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Early uptake of semaglutide for type 2 diabetes in Scandinavia and characteristics of initiators in Denmark: A register‐based drug utilization study | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.6f699326-fa8b-472a-a92d-3b5466b8b5ee_B.pdf
- Tamaño:
- 602.73 KB
- Formato:
- Adobe Portable Document Format